|本期目录/Table of Contents|

[1]奉婧,魏娟,汪芳裕.克罗恩病合并腹盆腔脓肿的内科治疗进展[J].医学研究与战创伤救治(原医学研究生学报),2022,24(1):54-58.[doi:10.3969/j.issn.1672-271X.2022.01.012]
　FENG Jing,WEI Juan,WANG Fang-yu.Progress in medical treatment of abdominal and pelvic abscess in Crohn’s disease[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2022,24(1):54-58.[doi:10.3969/j.issn.1672-271X.2022.01.012]
点击复制

克罗恩病合并腹盆腔脓肿的内科治疗进展()
分享到62.8K

《医学研究与战创伤救治》（原医学研究生学报）[ISSN:1672-271X/CN:32-1713/R]

卷:
第24卷
期数:
2022年1期
页码:
54-58
栏目:
综述
出版日期:
2022-02-20

文章信息/Info

Title:
Progress in medical treatment of abdominal and pelvic abscess in Crohn’s disease
作者:
奉婧; 魏娟; 汪芳裕
作者单位：210002南京，南方医科大学南京临床医学院（东部战区总医院）消化内科（奉婧、魏娟、汪芳裕)
Author(s):
FENG Jing ;  WEI Juan;  WANG Fang-yu
(Department of Gastroenterology and Hepatology, Jinling Hospital, Nanjing School Clinical Medicine, Southern Medical University / General Hospital of Eastern Theater Command, PLA, Nanjing 210002, Jiangsu, China)
关键词:
克罗恩病; 腹盆腔脓肿; 腹腔脓肿; 内科治疗
Keywords:
Crohn’s disease;  abdominopelvic abscess;  abdominal abscess;  medical treatment
分类号:
R574
DOI:
10.3969/j.issn.1672-271X.2022.01.012
文献标志码:
A
摘要:
自发性腹盆腔脓肿是克罗恩病（CD）的严重并发症。如何对CD合并自发性腹盆腔脓肿患者实施个体化治疗目前仍是临床工作的难点。近年来，随着用药实践及经皮脓肿穿刺引流技术的日益成熟，越来越多CD合并自发性腹盆腔脓肿的患者可通过内科手段获得良好的治疗效果，部分患者可延迟甚至避免手术。文章结合关于CD合并自发性腹盆腔脓肿的最新研究证据及国内外相关指南，对其内科治疗进展进行综述。
Abstract:
A spontaneous abdominopelvic abscess is one serious complication of Crohn’s disease (CD). Establishing an appropriate individualized treatment plan for CD complicated with spontaneous abdominopelvic abscess is difficult in clinical practice. In recent years, with the development of medication practices and percutaneous abscess drainage (PAD), an increasing number of patients with abdominopelvic abscess achieve a good therapeutic effect which results in delaying or even avoiding surgery after medical treatment. According to related researches and guidelines from home and abroad, thismanuscript summarizes the progress of medical treatment for CD complicated with spontaneous abdominopelvic abscess, which aims to provide more evidence for the rational clinical treatment of the disease.

参考文献/References:

[1]Matsui T, Sakurai T, Yamaguchi A, et al. The clinical characteristics and outcome of intraabdominal abscess in Crohn’s disease[J]. J Gastroenterol, 2004, 39(5): 441-448.
[2]Feagins LA, Holubar SD, Kane SV, et al. Current Strategies in the Management of Intra-abdominal Abscesses in Crohn’s Disease[J]. Clin Gastroenterol Hepatol, 2011, 9(10): 842-850.
[3]Ananthakrishnan AN, McGinley EL. Treatment of Intra-Abdominal Abscesses in Crohn’s Disease-A Nationwide Analysis of Patterns and Outcomes of Care[J]. Dig Dis Sci, 2013, 58(7): 2013-2018.
[4]Beaugerie L, Seksik P, Nion-Larmurier I, et al. Predictors of Crohn’s Disease[J]. Gastroenterology, 2006, 130(3): 650-656.
[5]Gionchetti P, Dignass A, Danese S, et al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 2: Surgical Management and Special Situations[J]. J Crohns Colitis, 2017, 11(2): 135-149.
[6]Reuken PA, Kruis W, Maaser C, et al. Microbial Spectrum of Intra-Abdominal Abscesses in Perforating Crohn’s Disease: Results from a Prospective German Registry[J].J Crohns Colitis, 2018, 12(6): 695-701.
[7]Park SK, Kim KJ, Lee SO, et al. Ciprofloxacin Usage and Bacterial Resistance Patterns in Crohn’s Disease Patients With Abscesses[J]. J Clin Gastroenterol, 2014, 48(8): 703-707.
[8]Li G, Ren J, Wu Q, et al. Bacteriology of Spontaneous Intra-Abdominal Abscess in Patients with Crohn Disease in China: Risk of Extended-Spectrum Beta-Lactamase-Producing Bacteria[J]. Surg Infect, 2015, 16(4): 461-465.
[9]Bermejo F, Garrido E, Chaparro M, et al. Efficacy of Different Therapeutic Options for Spontaneous Abdominal Abscesses in Crohn’s Disease: Are Antibiotics Enough?[J] Inflamm Bowel Dis, 2012, 18(8): 1509-1514.
[10]Lee H, Kim YH, Kim JH, et al. Nonsurgical treatment of abdominal or pelvic abscess in consecutive patients with Crohn’s disease[J]. Dig Liver Dis, 2006, 38(9): 659-664.
[11]de Groof EJ，Carbonnel F，Buskens CJ, et al. Abdominal Abscess in Crohn’s Disease: Multidisciplinary Management[J]. Dig Dis, 2014, 32(s1): 103-109.
[12]熊洋洋, 钱家鸣. 克罗恩病合并腹腔脓肿的药物治疗[J]. 中华炎性肠病杂志, 2017(2): 71-73.
[13]Alkhouri RH, Bahia G, Smith AC, et al. Outcome of medical management of intraabdominal abscesses in children with Crohn disease[J]. J Pediatr Surg, 2017, 52(9): 1433-1437.
[14]Graham E, Rao K, Cinti S. Medical Versus Interventional Treatment of Intra-Abdominal Abscess in Patients With Crohn Disease[J]. Infect Dis (Auckl), 2017, 10: 117991611770173.
[15]Forbes A, Escher J, Hébuterne X, et al. ESPEN guideline: Clinical nutrition in inflammatory bowel disease[J]. Clin Nutr, 2017, 36(2): 321-347.
[16]Yang Q, Gao X, Chen H, et al. Efficacy of exclusive enteral nutrition in complicated Crohn’s disease[J]. Scand J Gastroenterol, 2017, 52(9): 995-1001.
[17]Zhu Y, Xu L, Liu W, et al. Safety and Efficacy of Exclusive Enteral Nutrition for Percutaneously Undrainable Abdominal Abscesses in Crohn’s Disease[J]. Gastroenterol Res Pract, 2017, 2017: 6360319.
[18]Zheng XB, Peng X, Xie XY, et al. Enteral nutrition is associated with a decreased risk of surgical intervention in Crohn’s disease patients with spontaneous intra-abdominal abscess[J]. Rev Esp Enferm Dig, 2017, 109(12): 834-842.
[19]Adamina M, Bonovas S, Raine T, et al. ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment[J].J Crohns Colitis, 2020, 14(2): 155-168.
[20]He X, Lin X, Lian L, et al. Preoperative Percutaneous Drainage of Spontaneous Intra-Abdominal Abscess in Patients With Crohn’s Disease: A Meta-Analysis[J]. J Clin Gastroenterol, 2015, 49(9): e82-e90.
[21]Nguyen DL, Nguyen ET, Bechtold ML. Outcomes of initial medical compared with surgical strategies in the management of intra-abdominal abscesses in patients with Crohn’s disease: a meta-analysis[J]. Eur J Gastroenterol Hepatol, 2015, 27(3): 235-241.
[22]Clancy C, Boland T, Deasy J, et al. A Meta-analysis of Percutaneous Drainage Versus Surgery as the Initial Treatment of Crohn’s Disease-related Intra-abdominal Abscess[J].J Crohns Colitis, 2016, 10(2): 202-208.
[23]王郑君, 刘建强, 王雯. 粪菌移植在炎症性肠病中的研究进展[J]. 医学研究生学报, 2019, 32(8): 891-896.
[24]彭丽娜, 蔡淦, 丛军. 粪菌移植治疗溃疡性结肠炎的研究进展[J]. 东南国防医药, 2017, 19(2): 171-174.
[25]Cheng F, Huang Z, Wei W, et al. Fecal microbiota transplantation for Crohn’s disease: a systematic review and meta-analysis[J]. Tech Coloproctol, 2021, 25(5): 495-504.
[26]He Z, Li P, Zhu J, et al. Multiple fresh fecal microbiota transplants induces and maintains clinical remission in Crohn’s disease complicated with inflammatory mass[J]. Sci Rep, 2017, 7(1): 4753.
[27]Shen B. Exploring endoscopic therapy for the treatment of Crohn’s disease-related fistula and abscess[J]. Gastrointest Endosc, 2017, 85(6): 1133-1143.
[28]Hirten RP, Shah S, Sachar DB, et al. The Management of Intestinal Penetrating Crohn’s Disease[J]. Inflamm Bowel Dis, 2018, 24(4): 752-765.
[29]da Luz Moreira A，Stocchi L，Tan E, et al. Outcomes of Crohn’s Disease Presenting with Abdominopelvic Abscess[J]. Dis Colon Rectum, 2009, 52(5): 906-912.
[30]何晓生, 郑晓彬, 练磊, 等. 合并自发性腹腔脓肿的克罗恩病患者需早期手术的影响因素分析[J]. 中华胃肠外科杂志, 2016, 19(12): 1379-1383.
[31]Nguyen DL, Sandborn WJ, Loftus EV, et al. Similar Outcomes of Surgical and Medical Treatment of Intra-abdominal Abscesses in Patients With Crohn’s Disease[J]. Clin Gastroenterol Hepatol, 2012, 10(4): 400-404.
[32]陈媛媛, 魏娟, 孙晓伟, 等. 5-氨基水杨酸和免疫抑制剂药物预防上消化道型克罗恩病复发的疗效与安全性分析[J]. 医学研究生学报, 2021, 34(3): 252-257.
[33]孟松, 吴文溪. 炎症性肠病的免疫治疗进展[J]. 医学研究生学报, 2010, 23(9): 972-976.
[34]炎症性肠病外科治疗专家共识[J]. 中华炎性肠病杂志, 2020，4(3): 180-199.
[35]Pugmire BS, Gee MS, Kaplan JL, et al. Role of percutaneous abscess drainage in the management of young patients with Crohn disease[J]. Pediatr Radiol, 2016, 46(5): 653-659.
[36]Pineton de Chambrun G, Pariente B, Seksik P, et al. Adalimumab for patients with Crohn’s disease complicated by intra-abdominal abscess: a multicentre, prospective, observational cohort study[J].J Crohns Colitis, 2019, 13(Supplement_1): S616.
[37]Yoneno K, Hisamatsu T, Matsuoka K, et al. Risk and Management of Intra-Abdominal Abscess in Crohn’s Disease Treated with Infliximab[J]. Digestion, 2014, 89(3): 201-208.
[38]Sands BE, Blank MA, Diamond RH, et al. Maintenance infliximab does not result in increased abscess development in fistulizing Crohn’s disease: results from the ACCENT II study[J]. Aliment Pharmacol Ther, 2006, 23(8): 1127-1136.
[39]Collard MK, Benoist S, Maggiori L, et al. A Reappraisal of Outcome of Elective Surgery After Successful Non-Operative Management of an Intra-Abdominal Abscess Complicating Ileocolonic Crohn’s Disease: A Subgroup Analysis of a Nationwide Prospective Cohort[J]. J Crohns Colitis, 2021, 15(3): 409-418.

相似文献/References:

[1]薛 松,魏 磊,程 文,等.克罗恩病膀胱瘘3例报告[J].医学研究与战创伤救治(原医学研究生学报),2013,15(01):64.
[2]王珂,徐金中,黄迎春,等.外科加速康复团队在护理克罗恩病患者中的应用与效果观察[J].医学研究与战创伤救治(原医学研究生学报),2017,19(03):311.[doi:10.3969/j.issn.1672-271X.2017.03.023]
[3]印中鹏,宋令雄,王苏梦,等.血浆抗凝血酶Ⅲ和血清IL-6与降钙素原对判断克罗恩病活动性的临床价值[J].医学研究与战创伤救治(原医学研究生学报),2018,20(01):22.[doi:10.3969/j.issn.1672-271X.2018.01.005]
　YIN Zhong-peng,SONG Ling-xiong,WANG Su-meng,et al.Clinical value of plasma AT-Ⅲ and serum PCT, IL-6 levels and the evaluations of disease activity in Crohn′s disease[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2018,20(1):22.[doi:10.3969/j.issn.1672-271X.2018.01.005]
[4]陈媛媛,赵丽综述,汪芳裕,等.上消化道克罗恩病的临床特征及诊治现状与分析[J].医学研究与战创伤救治(原医学研究生学报),2020,22(4):385.[doi:10.3969/j.issn.1672-271X.2020.04.011]
　CHEN Yuan-yuan,ZHAO Li reviewing,WANG Fang-yu,et al.Clinical characteristics, diagnosis and treatment status and analysis of Crohn’s disease with upper gastrointestinal tract phenotype[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2020,22(1):385.[doi:10.3969/j.issn.1672-271X.2020.04.011]

备注/Memo

备注/Memo:
基金项目：国家自然科学基金 (81873559)
更新日期/Last Update: 2022-02-21